(二)、結果與討論 
(A) MM-Based Cell-Cycle Petri-Net Model 
Cyclin-dependent protein kinases (Cdks) is the central molecules in cell cycle network [1, 2, 
3] in Fig. 1. During the whole cell cycle, Cdk molecules keeps constant concentration but have 
different activation as combined with various Cyclins. In G1 state, Cdk activity is low due  to 
cyclin partners missing. At Start, the activity rises dramatically since Cyclin synthesis induces. 
This phenomena keeps for throughout S, G2 and M phases. At Finish, the activity must to be 
removed. That is, the activity needs to be low from Finish to next Start. Besides, APC 
(anaphase-promoting complex) is activated; Cdc20 and cdh1 included in APC are to recognize 
specific target proteins. Cyclin/Cdk can activate Cdc20 and inhibit Cdh1. In G1 state, Cdh1/APC 
activity is high but  Cyclin/Cdk activity is low. In S-G2-M state, Cyclin/Cdk activity is high but 
Cdh1/APC activity is low. 
 
Figure 1. Eukaryotic cell cycle [3] 
 2
Tyson and Novak (2001) made some assumptions.  Cyclin B molecules combine rapidly 
with an excess of Cdk subunits such that we do not have to keep track of CycB and Cdk 
monomers. Total Cdh1 concentration is constant and scaled to 1. Total hypothetical 
“ intermediary enzyme” concentration is constant and scaled to 1.In Fig. 2 CycB is generate from 
amino acids. Cyclin B molecules combine with an excess of Cdk subunits into CycB/Cdk. The 
concentrate rate of CycB/Cdk is determined by synthesis rate-constant , and degradation 
rate-constant  and  which is dependent on Cdh1/Apc’s activity. Activative Cdh1/Apc 
causes CycB/Cdk decomposed to CycB and Cdk monomers, and there CycB monomer degrades 
directly.  activates Cdh1/APC with rate-constants  and  . Cdh1/APC is inhibited 
by CycB/Cdk with rate-constant . In here, the cell mass plays an important role by connecting 
Start transition to cell growth. The generation rate of origin (inactive) Cdc20 is determined by 
CycB/Cdk and cell mass with rate-constant  and . Checkpoint-gene Mad affects cdc20 
inactivity via rate-constant . Both activate  and inactivate Cdc20 degrade directly 
1k
'
2k
''
2k
ACdc20
'
3k
''
3k
4k
'
5k
''
5k
8k ACdc20
將細胞週期控制系統之 HFPN 模型經過模擬後，我們可以得到 Fig. 4。 
 
 
 
Figure 4. HPFN 模擬結果 
 
 (B) 混和差值演算法 
In this year we deal with the entire cell-cycle which includes cell division. It is much more 
complicated than mitotic control for first year, and so, HDE learning procedures should be 
modified. We here examine three small bio-systems first, and then, further use the modified HDE 
to derive the S-like model of a cell-cycle regulatory system. 
HDE is a parallel direct search algorithm: 
(a) initialization  
0
min max min( ), 1,...,i rP P I P P i n= + − = p  
(b) mutation operation 
 4
Three totally different characteristic bio-systems are used: the cascade network in Fig. 6a (3 
dimension with 8 parameters), the small genetic network in Fig. 6b (8 dimension with 18 
parameters) and the branch network in Fig. 6c (5 dimension with 10 parameters). 
  
Fig. 6a                          Fig. 6b                    Fig. 6c 
Figure 6.  Three small bio-systems. 
The simulation results are shown as follows. From the results we know S-like model has 
comparable performance as S system. Therefore it is suitable for cell-cycle modeling.  
0 1 2 3 4 5 6 7 8
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
Cascade Netwok
time [min]
co
nc
en
tr
at
io
n
x1
x2
x3
Fig. 7a 
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5
0.4
0.5
0.6
0.7
0.8
0.9
1
1.1
Small Genetic Network
time [min]
co
nc
en
tr
at
io
n
x1
x2
x3
x4
x5
Fig. 7b 
0 1 2 3 4 5 6 7 8
0
0.5
1
1.5
2
2.5
3
3.5
Branch Network
time [min]
co
nc
en
tr
at
io
n
x1
x2
x3
x4
 
Fig. 7c 
Figure 7.  The simulation results  of three small bio-systems. ‘+’ denotes true data. ‘o’ denotes 
estimated data from S-system. The solid curves is the estimated values from S-like system. 
 6
been reported, but no model for the whole EFGR map has been reported. Since signal 
transduction forms a robust network and different cancers turn on different pathways, we first 
propose a growth-signalling-pathway blueprint in Fig. 14. Based on this blueprint and the 
corresponding quantitative HFPN model is developed. The model is further modified to 
satisfy the published experimental observations. Figure 15 shows the simulation results for 
general cells in normal environment (a), blood-tube cells in normal environment (b) and 
general cells in stress stimulation (c). 
 
 
Figure 14. Growth-signal Transduction biopathway.  
 
 
(a) (b) (c) 
Figure 15. Simulation Results. 
  
Reference 
[A1] Gonick, L., Wheelis, M., The Cartoon Guide to Genetics, Collins, 1991. 
[A2] Tsai, K.Y. and Wang, F.S., “Evolutionary Optimization with Data Collocation for Reverse 
Engineering of Biological Networks”, Bioinformatics, Vol. 21, p.p. 1180–1188, 2005. 
[A3] Chiang, C.L., Su, C.T. and Wang, F.S., “Augmented Lagrangian Method for Evolutionary 
Optimization of Mixed-Integer Nonlinear Constrained Problems”, Intern. Math. Journal, Vol. 
2, No. 2, p.p. 119–154, 2002. 
[A4] Chiou, J. P. and Wang, F. S., “A hybrid method of differential evolutionary with 
 8
 10
可供推廣之研發成果資料表 
□ 可申請專利  5可技術移轉                                      日期：99年9月11日 
國科會補助計畫 
計畫名稱：基於計算智慧之癌細胞調控機制之研究(II) 
計畫主持人：吳幸珍         
計畫編號：NSC 98-2221-E-212-032             
學門領域：系統生物研究 
技術/創作名稱 
A blueprint for dynamic-and-quantitative growth-signal transduction  
networks. 
Dynamic crosstalk in a cell-cycle regulatory system 
發明人/創作人 吳幸珍 
中文：1.整合各種網路上片斷bio-pathways 資訊，以 HFPN 技術來
建構癌細胞之生長訊息傳遞路徑基因網路。 2.直接切入細胞週期的
調控，以 HFPN 技術來建構動態定量視覺化網路。 3.利用混合差值
演算法的演化計算，以S-like system 為基因調控網路的架構推導
出基因調控網路模型。 
 
技術說明 英文：1. We integrate various website-piecewise bio-pathways and use HFPN technology to construct dynamic-and-quantitative 
growth-signal-transduction oncogne-and-anticognes networks。2. We 
cut into cell-cycle control and use HFPN to get a 
dynamic-and-quantitative visualization gene networks。3. Use 
proposed modified HDE technology to get S-like models of three 
small genetic biological systems and further a cell cycle regulatory 
system. Those models can reduce around half of parameters as 
compared to the S system modeling but have comparable performance。
可利用之產業 
及 
可開發之產品 
提供製藥業， 找到 growth signal-transduction mechanism 及
cell-cycle control 之 target genes ，以進一步研發新藥。 
技術特點 
1. dynamic-and-quantitative growth-signal-transduction mechanism。
2. dynamic-and-quantitative cell-cycle genes interaction。 
3. 突破多維建模問題。 
推廣及運用的價值 
1. 提供癌症研究者，一動態定量的 cell-cycle gene-network，
以利做模擬研究。 
2. 提供生物科技業，建立 genes 間直接互動的 HDE 建模技術，並
突破多維建模問題。 
※ 1.每項研發成果請填寫一式二份，一份隨成果報告送繳本會，一份送 貴單位
研發成果推廣單位（如技術移轉中心）。 
※ 2.本項研發成果若尚未申請專利，請勿揭露可申請專利之主要內容。 
※ 3.本表若不敷使用，請自行影印使用。 
98年度專題研究計畫研究成果彙整表 
計畫主持人：吳幸珍 計畫編號：98-2221-E-212-032- 
計畫名稱：基於計算智慧之癌細胞調控機制之研究(II) 
量化 
成果項目 實際已達成
數（被接受
或已發表）
預期總達成
數(含實際已
達成數) 
本計畫實
際貢獻百
分比 
單位 
備 註 （ 質 化 說
明：如數個計畫
共同成果、成果
列 為 該 期 刊 之
封 面 故 事 ...
等） 
期刊論文 0 0 100%  
研究報告/技術報告 0 1 100%  
研討會論文 0 0 100% 
篇 
 
論文著作 
專書 0 0 100%   
申請中件數 0 0 100%  專利 已獲得件數 0 0 100% 件  
件數 0 0 100% 件  
技術移轉 
權利金 0 0 100% 千元  
碩士生 0 1 100%  
博士生 0 1 100%  
博士後研究員 0 0 100%  
國內 
參與計畫人力 
（本國籍） 
專任助理 0 0 100% 
人次 
 
期刊論文 0 3 100%  
研究報告/技術報告 0 0 100%  
研討會論文 0 3 100% 
篇 
 
論文著作 
專書 0 0 100% 章/本  
申請中件數 0 0 100%  專利 已獲得件數 0 0 100% 件  
件數 0 0 100% 件  
技術移轉 
權利金 0 0 100% 千元  
碩士生 0 0 100%  
博士生 0 0 100%  
博士後研究員 0 0 100%  
國外 
參與計畫人力 
（外國籍） 
專任助理 0 0 100% 
人次 
 
 
